Synthesis of New Pyrazolo[3,4-d]pyrimidine Derivatives: NMR Spectroscopic Characterization, X-Ray, Hirshfeld Surface Analysis, DFT, Molecular Docking, and Antiproliferative Activity Investigations
Molecules · 2024
DOI: 10.3390/molecules29215020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Mohamed El Hafi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, Mohammed First University, Oujda 60000, Morocco. Hauptthemen laut MEDLINE: Pyrimidines, Molecular Docking Simulation, Cell Proliferation, Pyrazoles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors extend their appreciation to Princess Nourah bint Abdulrahman University re-searcher supporting project number (PNURSP2024R342), Princess Nourah bi…, The authors also extend their appreciation to the Researchers Supporting Project number (RSPD2024R754), King Saud University, Riyadh 11451, Saudi Arabia for su…, This study is supported via funding from Prince Sattam bin Abdulaziz University project number (PSAU/2023/R/1445).
Abstract (Originalsprache)
Four new pyrazolo[3,4-d]pyrimidines (P1–P4) were successfully synthesized in good relative yields by reacting 3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ol with various alkylating agents (methyl iodide, propargyl bromide, and phenacyl bromide) at room temperature in DMF solvent, employing liquid–solid phase transfer catalysis. The P1–P4 structures were elucidated using NMR spectroscopy and X-ray diffraction. Intermolecular interactions in P1–P4 were analyzed via Hirshfeld surface analysis and 2D fingerprint plots. Geometrical parameters were accurately modeled by DFT calculations using the B3LYP hybrid functional combined with a 6–311++G(d,p) basis set. The antiproliferative activity of P1–P4 towards colorectal carcinoma (HCT 116), human hepatocellular carcinoma (HepG2), and human breast cancer (MCF-7) cell lines, along with one normal cell line (WI38) was investigated using the MTT assay and sunitinib as a reference. Compounds P1 and P2 exhibited antiproliferative activities comparable to the reference drug towards all tested cells, with an IC50 range of 22.7–40.75 µM. Both compounds also showed high selectivity indices and minimal cytotoxic effects on the normal cell line. Molecular docking revealed that the significant antiproliferative activity may attributed to the number and type of intermolecular hydrogen bonding established between pyrazolo[3,4-d]pyrimidines and DNA topoisomerase, a common target for various anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Pharmacy, Mohammed First University, Oujda 60000, Morocco.
- Laboratory of Heterocyclic Organic Chemistry, Department of Chemistry, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco.
- Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
- Institute of Chemistry, ELTE Eötvös Loránd University, Pázmány P. sétány 1/A, 1117 Budapest, Hungary.
- Department of Chemistry, Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakech 40000, Morocco.
- Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
ORCID-Profile: Mohamed El Hafi, El Hassane Anouar, Sanae Lahmidi, Mohammed Boulhaoua, Mohammed Loubidi, Ashwag S Alanazi, Insaf Filali, Joel T Mague
Förderung
- The authors extend their appreciation to Princess Nourah bint Abdulrahman University re-searcher supporting project number (PNURSP2024R342), Princess Nourah bi…
- The authors also extend their appreciation to the Researchers Supporting Project number (RSPD2024R754), King Saud University, Riyadh 11451, Saudi Arabia for su…
- This study is supported via funding from Prince Sattam bin Abdulaziz University project number (PSAU/2023/R/1445)
- Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
- King Saud University, Riyadh, Saudi Arabia
Zitieren
APA
El Hafi, M., Anouar, E. H., Lahmidi, S., Boulhaoua, M., Loubidi, M., Alanazi, A. S., Filali, I., Hefnawy, M., El Ghayati, L., Mague, J. T., & Essassi, E. M. (2024). Synthesis of New Pyrazolo[3,4-d]pyrimidine Derivatives: NMR Spectroscopic Characterization, X-Ray, Hirshfeld Surface Analysis, DFT, Molecular Docking, and Antiproliferative Activity Investigations. Molecules. https://doi.org/10.3390/molecules29215020
Vancouver
El Hafi M, Anouar EH, Lahmidi S, Boulhaoua M, Loubidi M, Alanazi AS, et al. Synthesis of New Pyrazolo[3,4-d]pyrimidine Derivatives: NMR Spectroscopic Characterization, X-Ray, Hirshfeld Surface Analysis, DFT, Molecular Docking, and Antiproliferative Activity Investigations. Molecules. 2024. doi:10.3390/molecules29215020
BibTeX
@article{ElHafi2024,
author = {El Hafi, Mohamed and Anouar, El Hassane and Lahmidi, Sanae and Boulhaoua, Mohammed and Loubidi, Mohammed and Alanazi, Ashwag S and Filali, Insaf and Hefnawy, Mohamed and El Ghayati, Lhoussaine and Mague, Joel T and Essassi, El Mokhtar},
title = {Synthesis of New Pyrazolo[3,4-d]pyrimidine Derivatives: NMR Spectroscopic Characterization, X-Ray, Hirshfeld Surface Analysis, DFT, Molecular Docking, and Antiproliferative Activity Investigations},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29215020}
}
EUVIMED